Ginkgo Bioworks launched the CFPS Disulfide Premium portfolio, built for oxidative folding right out of the kit.

Public source

Publisher name

Public post

When we launched our Ginkgo Reagents Cell Free Protein Synthesis (CFPS) portfolio, one question kept coming up: what about disulfide bonds? Tomorrow, Sept 9, that change…

Log in to read the full post

Company

Ginkgo Bioworks

Industry
Biotechnology Research
Location
Boston, US
Company size
201–500 employees

About Ginkgo Bioworks

Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. We offer autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo's in-house autonomous lab is also available as a "cloud lab" through our Datapoints and Solutions contract research services.

See more

Latest activity

15 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.